Nancy Q. Liu

2.0k citations
30 papers · 1.5k indexed · h-index 17

Nancy Q. Liu

30 papers receiving 1.4k citations

Peers

Nancy Q. Liu
Comparison fields: 5 of 99
  • Pathology and Forensic Medicine 488
  • Molecular Biology 403
  • Immunology 193
  • Surgery 183
  • Epidemiology 183
Replace Ruhangiz T. Kilani with:
Ruhangiz T. Kilani Canada
Afshin Fayyazi Germany
Paolo Piazza Italy
Kok Loon Wong Singapore
Azadeh Goodarzi Iran
Georgina Xanthou Greece
Audrey Varin France
Ángeles Domínguez‐Soto Spain
Maurizio Marchini Italy
Hao Tang China
Nancy Q. Liu relative to Ruhangiz T. Kilani Canada Ruhangiz T. Kilani's profile →
Citations per field
00.5×6.0×
Ruhangiz T. Kilani · 1×
Citations per year

Countries citing papers authored by Nancy Q. Liu

Since Specialization
Citations

This map shows the geographic impact of Nancy Q. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Q. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Q. Liu more than expected).

Fields of papers citing papers by Nancy Q. Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Q. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Q. Liu. The network helps show where Nancy Q. Liu may publish in the future.

Co-authorship network of co-authors of Nancy Q. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Q. Liu. A scholar is included among the top collaborators of Nancy Q. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Q. Liu. Nancy Q. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 11
4 20
5 14
6 13
7 3
8 13
9 39
10 18
11 4
12 17
13 28
14 108
15 205
16 33
17 34
18 82
19
The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
14
20 123

About Nancy Q. Liu

Nancy Q. Liu is a scholar working on Pathology and Forensic Medicine, Rheumatology and Virology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Vitamin D Research Studies (9 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Virology (129 citations), Pathology and Forensic Medicine (488 citations) and Obstetrics and Gynecology (137 citations). Nancy Q. Liu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Martin Hewison, Venu Lagishetty, Yi Ouyang, Jay R. Lieberman, Rene F. Chun, John S. Adams, Thomas S. Lisse, Milan Fiala, Waldemar Popik and Michael Bukrinsky. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026